Alexion Pharmaceuticals, Inc. (ALXN)

This is a formal shareholder letter from Elliott Advisors to Alexion Pharmaceuticals, dated May 12, 2020.

Slide schematic 5/5

other 1/1 paragraph 3/3 source-note 1/1

Components 5

unclassified paragraph paragraph paragraph source-note

Tools 1

Thesis: Activist defense (for management) slide · 70%

However, the Portola announcement's profoundly negative impact on shareholder value – erasing approximately $1.7 billion from the Company's market capitalization in a single day – has led us to concl

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.